Dycom Industries, Inc. filings document the company’s operating results, governance structure, capital arrangements and material corporate events as a New York Stock Exchange-listed issuer. Form 8-K disclosures cover quarterly and annual results materials, board appointments and changes, and amendments to credit agreements, including senior secured Term Loan B financing.
Dycom’s proxy filings describe director elections, board composition, independence determinations, director compensation, executive compensation and shareholder voting matters. The filing record also identifies the company’s common stock, capital-structure disclosures, material agreements and governance practices related to its specialty contracting and building infrastructure businesses.
DYCOM INDUSTRIES INC director Richard K. Sykes acquired 197 shares of common stock on November 2, 2026, in a grant or award transaction; the reported price was $221.05 per share. His resulting direct holdings were 22,180 shares, including unvested Restricted Stock Units (RSUs).
Raejeanne Skillern, a director of Dycom Industries Inc. (DY), acquired 55 shares of common stock through a grant or award on November 2, 2026. The reported per-share transaction price was $221.05. Her direct holdings after the transaction were 544 shares, including unvested Restricted Stock Units (RSUs).
Dycom Industries Inc. (DY) director Stephen O. LeClair reported a grant/award acquisition of 68 common shares on November 2, 2026, with a reported transaction price of $221.05 per share. His reported direct holdings after the transaction were 865 shares, including unvested Restricted Stock Units (RSUs).
Dycom Industries Inc director Michael C. Lenz acquired 108 shares of common stock in a grant/award on November 2, 2026, at $221.05 per share. His direct holdings following the transaction were 451 shares, including unvested Restricted Stock Units (RSUs).
Dycom Industries Inc. director Philip R. Gallagher reported a grant/award acquisition of 90 shares of common stock on November 2, 2026. The transaction lists a price of $221.05 per share. His directly held position after the transaction was 962 shares; the reported position includes unvested Restricted Stock Units (RSUs). This was a compensation-related award, not a market purchase.
Dycom Industries, Inc. (DY) shares are reported as beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. Each reporting person’s cover page lists 1,619,369 shares, or 5.4% of the class.
The cover pages list 1,608,530 shares of shared voting power and 1,619,369 shares of shared dispositive power; sole voting and dispositive power are each 0. The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers. The reporting persons state that the disclosure should not, by itself, be construed as an admission of beneficial ownership.
Dycom Industries Inc. Executive VP & COO Kevin M. Wetherington had 536 common shares withheld on October 7, 2026, for tax liability incident to vesting of restricted stock units; the reported per-share price was 290.43. He directly held 19,706 shares after the transaction, including unvested time-vesting restricted stock units.
Dycom Industries (DY) director Jennifer M. Fritzsche reported a proposed sale of 1,000 common shares through Charles Schwab & Co., with an approximate sale date of October 5, 2026 and an aggregate market value of $273,990.00. The notice also lists equity-compensation entries of 414 restricted stock units dated May 21, 2026, and 586 dated May 22, 2026.
DYCOM Industries Inc. director Carmen M. Sabater purchased 350 shares of common stock at $280.62 per share on September 23, 2026. Her reported direct holdings after the purchase were 7,154 shares, including unvested Restricted Stock Units. No Rule 10b5-1 plan was reported.
Dycom Industries Inc. (DY) President & CEO Daniel S. Peyovich reported an open‑market purchase of 850 shares of Common Stock on September 9, 2026. The weighted average purchase price was $296.76 per share, with individual trades executed between $296.30 and $297.04 per share.
Following this purchase, Peyovich directly holds 61,343 shares of Dycom common stock, which includes unvested time‑vesting restricted stock units ("TRSUs"), and indirectly holds an additional 10,000 shares by trust. No Rule 10b5‑1 trading plan is reported for these transactions.